...
首页> 外文期刊>Hematology. >Alteration of the gene expression profile of T-cell receptor αβ-modified T-cells with diffuse large B-cell lymphoma specificity
【24h】

Alteration of the gene expression profile of T-cell receptor αβ-modified T-cells with diffuse large B-cell lymphoma specificity

机译:具有弥漫性大B细胞淋巴瘤特异性的T细胞受体αβ修饰的T细胞基因表达谱的改变

获取原文
获取原文并翻译 | 示例
           

摘要

Antigen-specific, T-cell receptor (TCR)-modified cytotoxic T lymphocytes (CTLs) that target tumors are an attractive strategy for specific adoptive immunotherapy. Little is known about whether there are any alterations in the gene expression profile after TCR gene transduction in T cells. We constructed TCR gene-redirected CTLs with specificity for diffuse large B-cell lymphoma (DLBCL)-associated antigens to elucidate the gene expression profiles of TCR gene-redirected T-cells, and we further analyzed the gene expression profile pattern of these redirected T-cells by Affymetrix microarrays. The resulting data were analyzed using Bioconductor software, a two-fold cut-off expression change was applied together with anti-correlation of the profile ratios to render the microarray analysis set. The fold change of all genes was calculated by comparing the three TCR gene-modified T-cells and a negative control counterpart. The gene pathways were analyzed using Bioconductor and Kyoto Encyclopedia of Genes and Genomes. Identical genes whose fold change was greater than or equal to 2.0 in all three TCR gene-redirected T-cell groups in comparison with the negative control were identified as the differentially expressed genes. The differentially expressed genes were comprised of 33 up-regulated genes and 1 down-regulated gene including JUNB, FOS, TNF, INF-γ, DUSP2, IL-1B, CXCL1, CXCL2, CXCL9, CCL2, CCL4, and CCL8. These genes are mainly involved in the TCR signaling, mitogen-activated protein kinase signaling, and cytokine-cytokine receptor interaction pathways. In conclusion, we characterized the gene expression profile of DLBCL-specific TCR gene-redirected T-cells. The changes corresponded to an up-regulation in the differentiation and proliferation of the T-cells. These data may help to explain some of the characteristics of the redirected T-cells.
机译:靶向肿瘤的抗原特异性,T细胞受体(TCR)修饰的细胞毒性T淋巴细胞(CTL)是特异性过继免疫疗法的一种有吸引力的策略。关于TCR基因在T细胞中转导后基因表达谱是否有任何改变,鲜为人知。我们构建了特异性针对弥漫性大B细胞淋巴瘤(DLBCL)相关抗原的TCR基因重定向的CTL,以阐明TCR基因重定向的T细胞的基因表达谱,并进一步分析了这些重定向T的基因表达谱模式。 -细胞通过Affymetrix微阵列。使用Bioconductor软件分析所得数据,将两倍截止表达变化与谱图比率的反相关一起应用,以提供微阵列分析集。通过比较三个TCR基因修饰的T细胞和阴性对照对应物,计算所有基因的倍数变化。使用Bioconductor和《京都基因与基因组百科全书》分析了基因途径。与阴性对照相比,在所有三个TCR基因重定向的T细胞组中,倍数变化均大于或等于2.0的相同基因被鉴定为差异表达基因。差异表达的基因由33个上调基因和1个下调基因组成,包括JUNB,FOS,TNF,INF-γ,DUSP2,IL-1B,CXCL1,CXCL2,CXCL9,CCL2,CCL4和CCL8。这些基因主要参与TCR信号传导,丝裂原激活的蛋白激酶信号传导和细胞因子-细胞因子受体相互作用途径。总之,我们表征了DLBCL特异性TCR基因重定向的T细胞的基因表达谱。这些变化对应于T细胞的分化和增殖的上调。这些数据可能有助于解释重定向的T细胞的某些特征。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号